VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q57436781 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010727.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q57436781‏
024 ‎‡a 0000-0003-0405-4252‏ ‎‡2 orcid‏
024 ‎‡a 56587533400‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q57436781‏
100 0 ‎‡a Ellen M Janssen‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Ellen M Janssen‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
400 0 ‎‡a Ellen M Janssen‏ ‎‡c investigador‏ ‎‡9 es‏
670 ‎‡a Author's A cost analysis of implementing a behavioral weight loss intervention in community mental health settings: Results from the ACHIEVE trial‏
670 ‎‡a Author's A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes‏
670 ‎‡a Author's AcroVoice: eliciting the patients' perspective on acr Omega ly disease activity‏
670 ‎‡a Author's Analysis of Patient Preferences in Lung Cancer - Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects‏
670 ‎‡a Author's Art and Science of Instrument Development for Stated-Preference Methods.‏
670 ‎‡a Author's Assessing Rationality in Discrete Choice Experiments in Health: An Investigation into the Use of Dominance Tests‏
670 ‎‡a Author's Breeding performance of great tits‏
670 ‎‡a Author's Breeding performance of great tits (Parus major) along a gradient of heavy metal pollution‏
670 ‎‡a Author's Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis‏
670 ‎‡a Author's Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.‏
670 ‎‡a Author's Cost of behavioral weight loss programs implemented in clinical practice: The POWER trial at Johns Hopkins‏
670 ‎‡a Author's Demographic, health, and attitudinal factors predictive of cancer screening decisions in older adults‏
670 ‎‡a Author's Discussion: Research to Promote Patient-Based HTA‏
670 ‎‡a Author's Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment‏
670 ‎‡a Author's Effects of heavy metal exposure on the condition and health of adult great tits‏
670 ‎‡a Author's Effects of heavy metal exposure on the condition and health of adult great tits (Parus major).‏
670 ‎‡a Author's Effects of heavy metal exposure on the condition and health of nestlings of the great tit (Parus major), a small songbird species‏
670 ‎‡a Author's Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy‏
670 ‎‡a Author's Exploring variation in parental worries about HPV vaccination: a latent-class analysis‏
670 ‎‡a Author's How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event‏
670 ‎‡a Author's How Do Older Adults Consider Age, Life Expectancy, Quality of Life, and Physician Recommendations When Making Cancer Screening Decisions? Results from a National Survey Using a Discrete Choice Experiment‏
670 ‎‡a Author's Identifying and prioritizing concerns associated with prosthetic devices for use in a benefit-risk assessment: a mixed-methods approach‏
670 ‎‡a Author's Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability?‏
670 ‎‡a Author's Increasing the Patient-Centeredness of Health Economics and Outcomes Research Through Patient Engagement in Core Outcome Set Development‏
670 ‎‡a Author's Live, Learn, Pass It on: A Patient Advocacy Engagement Project on the Lived Experience of Lung Cancer Survivors.‏
670 ‎‡a Author's Older Adults' Preferences for Discussing Long-Term Life Expectancy: Results From a National Survey‏
670 ‎‡a Author's Preferred Clinician Communication About Stopping Cancer Screening Among Older US Adults: Results From a National Survey‏
670 ‎‡a Author's Project transform: engaging patient advocates to share their perspectives on improving research, treatment, and policy.‏
670 ‎‡a Author's Research as an event: a novel approach to promote patient-focused drug development.‏
670 ‎‡a Author's Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness‏
670 ‎‡a Author's The reproductive success and quality of blue tits‏
670 ‎‡a Author's The reproductive success and quality of blue tits (Parus caeruleus) in a heavy metal pollution gradient‏
670 ‎‡a Author's Using Best-Worst Scaling to Investigate Preferences in Health Care‏
909 ‎‡a (orcid) 0000000304054252‏ ‎‡9 1‏
909 ‎‡a (scopus) 56587533400‏ ‎‡9 1‏
919 ‎‡a educationandpatientpreferencesfortreatingtype2diabetesastratifieddiscretechoiceexperiment‏ ‎‡A Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment‏ ‎‡9 1‏
919 ‎‡a effectsofheavymetalexposureontheconditionandhealthofadultgreattits‏ ‎‡A Effects of heavy metal exposure on the condition and health of adult great tits‏ ‎‡9 1‏
919 ‎‡a effectsofheavymetalexposureontheconditionandhealthofadultgreattitsparusmajor‏ ‎‡A Effects of heavy metal exposure on the condition and health of adult great tits (Parus major).‏ ‎‡9 1‏
919 ‎‡a effectsofheavymetalexposureontheconditionandhealthofnestlingsofthegreattitparusmajorasmallsongbirdspecies‏ ‎‡A Effects of heavy metal exposure on the condition and health of nestlings of the great tit (Parus major), a small songbird species‏ ‎‡9 1‏
919 ‎‡a engagingpatientsandcaregiversinprioritizingsymptomsimpactingqualityoflifeforduchenneandbeckermusculardystrophy‏ ‎‡A Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy‏ ‎‡9 1‏
919 ‎‡a exploringvariationinparentalworriesabouthpvvaccinationalatentclassanalysis‏ ‎‡A Exploring variation in parental worries about HPV vaccination: a latent-class analysis‏ ‎‡9 1‏
919 ‎‡a howdomembersoftheduchenneandbeckermusculardystrophycommunityperceiveadiscretechoiceexperimentincorporatinguncertaintreatmentbenefitanapplicationofresearchasanevent‏ ‎‡A How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event‏ ‎‡9 1‏
919 ‎‡a howdoolderadultsconsideragelifeexpectancyqualityoflifeandphysicianrecommendationswhenmakingcancerscreeningdecisionsresultsfromanationalsurveyusingadiscretechoiceexperiment‏ ‎‡A How Do Older Adults Consider Age, Life Expectancy, Quality of Life, and Physician Recommendations When Making Cancer Screening Decisions? Results from a National Survey Using a Discrete Choice Experiment‏ ‎‡9 1‏
919 ‎‡a identifyingandprioritizingconcernsassociatedwithprostheticdevicesforuseinabenefitriskassessmentamixedmethodsapproach‏ ‎‡A Identifying and prioritizing concerns associated with prosthetic devices for use in a benefit-risk assessment: a mixed-methods approach‏ ‎‡9 1‏
919 ‎‡a improvingthequalityofdiscretechoiceexperimentsinhealthhowcanweassessvalidityandreliability‏ ‎‡A Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability?‏ ‎‡9 1‏
919 ‎‡a increasingthepatientcenterednessofhealtheconomicsandoutcomesresearchthroughpatientengagementincoreoutcomesetdevelopment‏ ‎‡A Increasing the Patient-Centeredness of Health Economics and Outcomes Research Through Patient Engagement in Core Outcome Set Development‏ ‎‡9 1‏
919 ‎‡a livelearnpassitonapatientadvocacyengagementprojectonthelivedexperienceoflungcancersurvivors‏ ‎‡A Live, Learn, Pass It on: A Patient Advocacy Engagement Project on the Lived Experience of Lung Cancer Survivors.‏ ‎‡9 1‏
919 ‎‡a olderadultspreferencesfordiscussinglongtermlifeexpectancyresultsfromanationalsurvey‏ ‎‡A Older Adults' Preferences for Discussing Long-Term Life Expectancy: Results From a National Survey‏ ‎‡9 1‏
919 ‎‡a preferredcliniciancommunicationaboutstoppingcancerscreeningamongolderusadultsresultsfromanationalsurvey‏ ‎‡A Preferred Clinician Communication About Stopping Cancer Screening Among Older US Adults: Results From a National Survey‏ ‎‡9 1‏
919 ‎‡a projecttransformengagingpatientadvocatestosharetheirperspectivesonimprovingresearchtreatmentandpolicy‏ ‎‡A Project transform: engaging patient advocates to share their perspectives on improving research, treatment, and policy.‏ ‎‡9 1‏
919 ‎‡a researchasaneventanovelapproachtopromotepatientfocuseddrugdevelopment‏ ‎‡A Research as an event: a novel approach to promote patient-focused drug development.‏ ‎‡9 1‏
919 ‎‡a reviewoftheevidenceprevalenceofmedicalconditionsintheunitedstatespopulationwithseriousmentalillness‏ ‎‡A Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness‏ ‎‡9 1‏
919 ‎‡a reproductivesuccessandqualityofbluetits‏ ‎‡A The reproductive success and quality of blue tits‏ ‎‡9 1‏
919 ‎‡a reproductivesuccessandqualityofbluetitsparuscaeruleusinaheavymetalpollutiongradient‏ ‎‡A The reproductive success and quality of blue tits (Parus caeruleus) in a heavy metal pollution gradient‏ ‎‡9 1‏
919 ‎‡a usingbestworstscalingtoinvestigatepreferencesinhealthcare‏ ‎‡A Using Best-Worst Scaling to Investigate Preferences in Health Care‏ ‎‡9 1‏
919 ‎‡a costanalysisofimplementingabehavioralweightlossinterventionincommunitymentalhealthsettingsresultsfromtheachievetrial‏ ‎‡A A cost analysis of implementing a behavioral weight loss intervention in community mental health settings: Results from the ACHIEVE trial‏ ‎‡9 1‏
919 ‎‡a frameworkforinstrumentdevelopmentofachoiceexperimentanapplicationtotype2diabetes‏ ‎‡A A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes‏ ‎‡9 1‏
919 ‎‡a acrovoiceelicitingthepatientsperspectiveonacr Omega lydiseaseactivity‏ ‎‡A AcroVoice: eliciting the patients' perspective on acr Omega ly disease activity‏ ‎‡9 1‏
919 ‎‡a analysisofpatientpreferencesinlungcancerestimatingacceptabletradeoffsbetweentreatmentbenefitandsideeffects‏ ‎‡A Analysis of Patient Preferences in Lung Cancer - Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects‏ ‎‡9 1‏
919 ‎‡a artandscienceofinstrumentdevelopmentforstatedpreferencemethods‏ ‎‡A Art and Science of Instrument Development for Stated-Preference Methods.‏ ‎‡9 1‏
919 ‎‡a assessingrationalityindiscretechoiceexperimentsinhealthaninvestigationintotheuseofdominancetests‏ ‎‡A Assessing Rationality in Discrete Choice Experiments in Health: An Investigation into the Use of Dominance Tests‏ ‎‡9 1‏
919 ‎‡a breedingperformanceofgreattits‏ ‎‡A Breeding performance of great tits‏ ‎‡9 1‏
919 ‎‡a breedingperformanceofgreattitsparusmajoralongagradientofheavymetalpollution‏ ‎‡A Breeding performance of great tits (Parus major) along a gradient of heavy metal pollution‏ ‎‡9 1‏
919 ‎‡a caregivertreatmentpreferencesforchildrenwithanewversusexistingattentiondeficithyperactivitydisorderdiagnosis‏ ‎‡A Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis‏ ‎‡9 1‏
919 ‎‡a conductingadiscretechoiceexperimentstudyfollowingrecommendationsforgoodresearchpracticesanapplicationforelicitingpatientpreferencesfordiabetestreatments‏ ‎‡A Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.‏ ‎‡9 1‏
919 ‎‡a costofbehavioralweightlossprogramsimplementedinclinicalpracticethepowertrialatjohnshopkins‏ ‎‡A Cost of behavioral weight loss programs implemented in clinical practice: The POWER trial at Johns Hopkins‏ ‎‡9 1‏
919 ‎‡a demographichealthandattitudinalfactorspredictiveofcancerscreeningdecisionsinolderadults‏ ‎‡A Demographic, health, and attitudinal factors predictive of cancer screening decisions in older adults‏ ‎‡9 1‏
919 ‎‡a discussionresearchtopromotepatientbasedhta‏ ‎‡A Discussion: Research to Promote Patient-Based HTA‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 NSK|000415448
996 ‎‡2 NTA|32777830X
996 ‎‡2 NTA|100367089
996 ‎‡2 LC|n 79089325
996 ‎‡2 NTA|070717516
996 ‎‡2 NTA|135748267
996 ‎‡2 NTA|072370823
996 ‎‡2 NTA|140289690
996 ‎‡2 NTA|395446465
996 ‎‡2 ISNI|0000000394164278
996 ‎‡2 NTA|190889225
996 ‎‡2 NTA|114397589
996 ‎‡2 ISNI|0000000395339228
996 ‎‡2 NTA|23893005X
996 ‎‡2 PLWABN|9810587074405606
996 ‎‡2 LC|no2019007673
996 ‎‡2 NTA|073057347
996 ‎‡2 ISNI|0000000392144353
996 ‎‡2 NTA|073474657
996 ‎‡2 NTA|436233509
996 ‎‡2 ISNI|0000000391263684
996 ‎‡2 NTA|072970383
996 ‎‡2 ISNI|000000042763437X
996 ‎‡2 ISNI|0000000391724014
996 ‎‡2 NTA|085007579
996 ‎‡2 NTA|364168803
996 ‎‡2 NTA|274521180
996 ‎‡2 NTA|161493688
996 ‎‡2 ISNI|0000000396331754
996 ‎‡2 NTA|070159874
996 ‎‡2 NTA|321322789
996 ‎‡2 NTA|110980794
996 ‎‡2 NTA|149063849
996 ‎‡2 NTA|192918613
996 ‎‡2 NTA|072369264
996 ‎‡2 NTA|274455528
996 ‎‡2 NTA|297695916
996 ‎‡2 LC|nb 98036185
996 ‎‡2 ISNI|0000000032837527
996 ‎‡2 NTA|067733352
996 ‎‡2 ISNI|0000000369165543
996 ‎‡2 NTA|304364517
996 ‎‡2 ISNI|0000000390536572
996 ‎‡2 LC|no2020014479
996 ‎‡2 NTA|068709048
996 ‎‡2 NTA|436233444
996 ‎‡2 RERO|A003420190
996 ‎‡2 NTA|421296151
996 ‎‡2 NTA|07260848X
996 ‎‡2 LC|no2014070705
996 ‎‡2 SUDOC|179401009
996 ‎‡2 DNB|1073366170
996 ‎‡2 NII|DA17235541
996 ‎‡2 NTA|238115178
996 ‎‡2 NTA|074303988
996 ‎‡2 LC|no2024003424
996 ‎‡2 ISNI|0000000392150892
996 ‎‡2 NTA|189923466
996 ‎‡2 NTA|070955891
996 ‎‡2 LC|ns2015003069
996 ‎‡2 RERO|A009095761
996 ‎‡2 ISNI|0000000395383050
996 ‎‡2 NUKAT|n 2016051522
996 ‎‡2 NTA|214064778
996 ‎‡2 NTA|175356467
996 ‎‡2 ISNI|0000000389601031
996 ‎‡2 DNB|1046978942
996 ‎‡2 NTA|412782227
996 ‎‡2 ISNI|0000000394843967
996 ‎‡2 NTA|095233245
996 ‎‡2 BIBSYS|99037607
996 ‎‡2 LC|n 91064995
996 ‎‡2 ISNI|0000000398190895
996 ‎‡2 ISNI|0000000392469668
996 ‎‡2 ISNI|0000000499923840
996 ‎‡2 NTA|408527072
996 ‎‡2 NTA|303250437
996 ‎‡2 NTA|315257547
996 ‎‡2 ISNI|0000000386997843
996 ‎‡2 NTA|436233495
996 ‎‡2 NTA|069390592
996 ‎‡2 NTA|073572640
996 ‎‡2 ISNI|0000000396759718
996 ‎‡2 NTA|06950296X
996 ‎‡2 BIBSYS|97033458
996 ‎‡2 ISNI|0000000388634325
996 ‎‡2 NTA|273407171
996 ‎‡2 SUDOC|192282883
996 ‎‡2 ISNI|0000000394400306
996 ‎‡2 SUDOC|133649466
996 ‎‡2 ISNI|0000000391436741
996 ‎‡2 ISNI|0000000397082542
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏